miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18607389 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.4 - Patient study phenotype-control quantitative PCR
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, mixed histotype - 0) Cancer ovary miRNA overexpression - 3.48 - Patient study phenotype-control miRNA microarray
18458333 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA downregulation - - - Cell culture study miRNA microarray
18381414 Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) Cancer HSC-3 cell miRNA downregulation - - - Cell culture study quantitative PCR
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 3.85 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA overexpression - 1.7 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA overexpression - 3.31 - Cell culture study quantitative PCR
18223217 Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) Cancer liver miRNA overexpression - 2.6 - Patient study phenotype-phenotype quantitative PCR
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA downregulation - 4.54545 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA overexpression - 1.77 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA overexpression - 3.26 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 1.96078 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 2.38095 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA overexpression - 1.17 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 8.33333 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA overexpression - 1.82 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 2.07 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 1.83 - Cell culture study quantitative PCR
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 3.46 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA overexpression - 1.62 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 5.31 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 1.68 - Bioprocess study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA overexpression - 1.91 - Cell culture study quantitative PCR
17191223 - - lung miRNA downregulation - - - Bioprocess study quantitative PCR